KRAS and pancreatic acinar cell carcinoma: In patient 7, who was diagnosed with a pancreatic acinar cell carcinoma exhibiting no KRAS mutations, the level of the KRAS G12/G13 variant was found to be approximately similar to the detection limit of the screening kit (0.2%).